RAPT Therapeutics (RAPT) Current Leases: 2022-2024
Historic Current Leases for Therapeutics (RAPT) over the last 3 years, with Sep 2024 value amounting to $2.5 million.
- Therapeutics' Current Leases rose 5.56% to $2.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.5 million, marking a year-over-year increase of 5.56%. This contributed to the annual value of $2.4 million for FY2023, which is 12.76% up from last year.
- According to the latest figures from Q3 2024, Therapeutics' Current Leases is $2.5 million, which was down 1.75% from $2.6 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Current Leases registered a high of $2.6 million during Q2 2024, and its lowest value of $1.5 million during Q1 2022.
- In the last 3 years, Therapeutics' Current Leases had a median value of $2.3 million in 2023 and averaged $2.2 million.
- Data for Therapeutics' Current Leases shows a peak YoY surged of 55.22% (in 2023) over the last 5 years.
- Over the past 3 years, Therapeutics' Current Leases (Quarterly) stood at $2.2 million in 2022, then climbed by 12.76% to $2.4 million in 2023, then rose by 5.56% to $2.5 million in 2024.
- Its Current Leases stands at $2.5 million for Q3 2024, versus $2.6 million for Q2 2024 and $2.5 million for Q1 2024.